Cargando…
Targeting the DNA Damage Response Machinery for Lung Cancer Treatment
Lung cancer is considered the most commonly diagnosed cancer and one of the leading causes of death globally. Despite the responses from small-cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC) patients to conventional chemo- and radiotherapies, the current outcomes are not satisfactory....
Autor principal: | Venugopala, Katharigatta N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9781725/ https://www.ncbi.nlm.nih.gov/pubmed/36558926 http://dx.doi.org/10.3390/ph15121475 |
Ejemplares similares
-
Regulation of the Cell-Intrinsic DNA Damage Response by the Innate Immune Machinery
por: Hayman, Thomas J., et al.
Publicado: (2021) -
Dynamic targeting of the replication machinery to sites of DNA damage
por: Solomon, David A., et al.
Publicado: (2004) -
Therapeutic Targeting of DNA Damage Response in Cancer
por: Choi, Wonyoung, et al.
Publicado: (2022) -
Targeting the DNA Damage Response for Cancer Therapy
por: Wang, Ruoxi, et al.
Publicado: (2023) -
Targeting the Calcium Signalling Machinery in Cancer
por: Bruce, Jason I. E., et al.
Publicado: (2020)